ArticleEClinicalMedicine2023

Evaluation of the efficacy and safety of TREM-1 inhibition with nangibotide in patients with COVID-19 receiving respiratory support: the ESSENTIAL randomised, double-blind trial.

Bruno François et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.